| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 24858 | 2017 |
| Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European … BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ... European heart journal 38 (32), 2459-2472, 2017 | 3234 | 2017 |
| Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of … BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ... European heart journal 34 (45), 3478-3490, 2013 | 3015 | 2013 |
| Lipoprotein (a) as a cardiovascular risk factor: current status BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ... European heart journal 31 (23), 2844-2853, 2010 | 2129 | 2010 |
| Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ... European heart journal 32 (11), 1345-1361, 2011 | 1588 | 2011 |
| Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) GF Watts, B Lewis, ES Lewis, DJ Coltart, LDR Smith, AV Swan, JNH Brunt, ... The Lancet 339 (8793), 563-569, 1992 | 1140 | 1992 |
| Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on … M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ... European heart journal 35 (32), 2146-2157, 2014 | 1106 | 2014 |
| Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European … J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ... European heart journal 41 (24), 2313-2330, 2020 | 1055 | 2020 |
| Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ... European heart journal 36 (36), 2425-2437, 2015 | 907 | 2015 |
| Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint … BG Nordestgaard, A Langsted, S Mora, G Kolovou, H Baum, E Bruckert, ... European heart journal 37 (25), 1944-1958, 2016 | 835 | 2016 |
| Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men TA Mori, V Burke, IB Puddey, GF Watts, DN O’Neal, JD Best, LJ Beilin The American journal of clinical nutrition 71 (5), 1085-1094, 2000 | 793 | 2000 |
| Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication M Benn, GF Watts, A Tybjaerg-Hansen, BG Nordestgaard The Journal of Clinical Endocrinology & Metabolism 97 (11), 3956-3964, 2012 | 788 | 2012 |
| Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab E Stroes, D Colquhoun, D Sullivan, F Civeira, RS Rosenson, GF Watts, ... Journal of the American College of Cardiology 63 (23), 2541-2548, 2014 | 680 | 2014 |
| The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association SS Gidding, M Ann Champagne, SD de Ferranti, J Defesche, MK Ito, ... Circulation 132 (22), 2167-2192, 2015 | 656 | 2015 |
| Improved analysis of brachial artery ultrasound using a novel edge-detection software system RJ Woodman, DA Playford, GF Watts, C Cheetham, C Reed, RR Taylor, ... Journal of applied physiology 91 (2), 929-937, 2001 | 639 | 2001 |
| Statin toxicity: mechanistic insights and clinical implications NC Ward, GF Watts, RH Eckel Circulation research 124 (2), 328-350, 2019 | 619 | 2019 |
| The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ... The lancet Diabetes & endocrinology 2 (8), 655-666, 2014 | 611 | 2014 |
| Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia PJ Chowienczyk, GF Watts, JR Cockcroft, JM Ritter The Lancet 340 (8833), 1430-1432, 1992 | 604 | 1992 |
| Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ... International journal of cardiology 171 (3), 309-325, 2014 | 582 | 2014 |
| Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension RJ Woodman, TA Mori, V Burke, IB Puddey, GF Watts, LJ Beilin The American journal of clinical nutrition 76 (5), 1007-1015, 2002 | 532 | 2002 |
